about
Proteomic analysis reveals that proteasome subunit beta 6 is involved in hypoxia-induced pulmonary vascular remodeling in ratsThe ubiquitin-proteasome system and cardiovascular diseaseThe ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathyAdrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in miceMyosin light chain phosphorylation is critical for adaptation to cardiac stress.Cardiac specific expression of threonine 5 to alanine mutant sarcolipin results in structural remodeling and diastolic dysfunctionThe ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective.Autophagy and the ubiquitin-proteasome system in cardiac dysfunction.Potential role of Hsp25 in calcium-modulated cardiomyocytes.Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts.Distinct cardiac transcriptional profiles defining pregnancy and exerciseTear me down: role of calpain in the development of cardiac ventricular hypertrophy.Proteasome functional insufficiency in cardiac pathogenesis.Ubiquitin receptors and protein quality controlAltered ubiquitin-proteasome signaling in right ventricular hypertrophy and failureCardiac metabolism in heart failure: implications beyond ATP production.The role of the proteasome in heart diseaseInnate immunity and remodelling.Proteasome inhibition slightly improves cardiac function in mice with hypertrophic cardiomyopathy.Clarifying the cardiac proteasome paradox: protein quality control.Genetically induced moderate inhibition of 20S proteasomes in cardiomyocytes facilitates heart failure in mice during systolic overload.Ubiquitin, a novel paracrine messenger of cardiac cell survival.Repeated intermittent administration of a ubiquitous proteasome inhibitor leads to restrictive cardiomyopathy.Emergence of Members of TRAF and DUB of Ubiquitin Proteasome System in the Regulation of Hypertrophic Cardiomyopathy
P2860
Q21132996-A92CFDBA-C8A2-490D-ABCF-8FC2C41F6C95Q27021582-BDFB425A-579E-4AF0-BBBB-54A97601AF35Q28252486-5CE80F3E-E5D6-4F44-A51F-28BA9F002449Q28252819-549C2C71-277D-4736-95FB-65C308571DF3Q28277846-CB73DBD5-D2A5-46FF-AA18-13849A09204CQ28543394-E9C7CC0C-1CA4-42FF-81A8-4045AE46E671Q33554497-D660325B-1F33-4BA1-BDE3-51454245722FQ33733547-121A9E89-DF60-488A-9DC6-42D6B297344AQ34090611-F4720EAC-2B6A-4994-ADBA-0240E05B53D8Q34275603-A4B62190-4487-47B6-875F-86137EAA54EFQ34364776-282CA0FF-7A58-4DD4-A2FA-C881B7D25506Q35151516-73118332-D771-4C62-978B-1E1F89E093C8Q35601400-4B8E636F-A752-4FFA-8EDA-6DA076F5B1B3Q36606405-A0A2A170-5423-48E4-88DA-E33D8638CFB1Q37476517-250D610F-DFBC-4DAF-A0BD-2CB492BBE084Q37495811-AE00711C-5B99-4CFD-875F-DB3D5D4C8A61Q37788836-047960C2-0A45-44FA-BA28-71A13CCE38FEQ41208076-5C3AEC28-3B76-4B43-9DE6-1B9BEF492AE5Q41825817-3E0C8DDB-5E05-40B6-9C95-DA959CA74611Q42382931-04F28CAC-B4CA-4D7B-A199-049BF893FC73Q42428235-254CCAE0-E2A0-4638-B765-0864AC50223EQ42874374-2A202DC0-E33E-455E-9AD4-4DFF82E1ABFCQ43154485-4D826F54-A245-4110-901F-F93C0F5244BEQ58728912-AA48D711-1611-4A4D-ABF0-40F2A587B552
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Proteasome inhibitors and cardiac cell growth
@ast
Proteasome inhibitors and cardiac cell growth
@en
Proteasome inhibitors and cardiac cell growth.
@nl
type
label
Proteasome inhibitors and cardiac cell growth
@ast
Proteasome inhibitors and cardiac cell growth
@en
Proteasome inhibitors and cardiac cell growth.
@nl
prefLabel
Proteasome inhibitors and cardiac cell growth
@ast
Proteasome inhibitors and cardiac cell growth
@en
Proteasome inhibitors and cardiac cell growth.
@nl
P2860
P356
P1476
Proteasome inhibitors and cardiac cell growth
@en
P2093
Christophe Depre
Nadia Hedhli
P2860
P304
P356
10.1093/CVR/CVP226
P577
2009-07-03T00:00:00Z